Safety and efficacy of JWATM204, a novel Glypican-3 (GPC3)-targeted CAR T cell therapy for advanced hepatocellular carcinoma: A phase I dose-escalation study

Authors

Institutions

Publication Details

Journal
Cancer Pathogenesis and Therapy
Published
2025-12-19
DOI
https://doi.org/10.1016/j.cpt.2025.12.002
Primary Topic
CAR-T cell therapy research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Safety and efficacy of JWATM204, a novel Glypican-3 (GPC3)-targeted CAR T cell therapy for advanced hepatocellular carcinoma: A phase I dose-escalation study

Jing Tang, Gang Wu, Jun Xue, Tao Zhang et al.
Cancer Pathogenesis and Therapy
CAR-T cell therapy research
article

Safety and efficacy of JWATM204, a novel Glypican-3 (GPC3)-targeted CAR T cell therapy for advanced hepatocellular carcinoma: A phase I dose-escalation study

Jing Tang, Gang Wu, Jun Xue, Tao Zhang, Zanyi Wu, Jinfeng Zhang, Jun Fan, Yongqiang Yang, Dongen Liu
article en

Abstract

No abstract available for this paper.
Cancer Pathogenesis and TherapyVol. 4(4)
Union Hospital (HK), Huazhong University of Science and Technology (CN)
Openalex Percentile: Top 43%
CAR-T cell therapy research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.